DUPILUMAB

438499 reported adverse events

Drug classes: Interleukin-4 Receptor alpha Antagonist [EPC]

These side effects are most commonly reported by patients taking DUPILUMAB:

# Side effect Count
0 PRURITUS 52379
1 DERMATITIS ATOPIC 41045
2 PRODUCT USE IN UNAPPROVED INDICATION 38078
3 RASH 35570
4 INJECTION SITE PAIN 32857
5 DRUG INEFFECTIVE 27750
6 ECZEMA 24172
7 PRODUCT DOSE OMISSION ISSUE 23332
8 DRY SKIN 23316
9 CONDITION AGGRAVATED 19621
See all common reactions for DUPILUMAB

DUPILUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND ATOPIC DERMATITIS 2022 0.9966
1 REBOUND ECZEMA 2011 0.9858
2 DERMATITIS ATOPIC 41045 0.9111
3 EOSINOPHILIC OESOPHAGITIS 1587 0.6921
4 NEURODERMATITIS 2058 0.6686
5 PERIORBITAL IRRITATION 186 0.6370
6 EXPOSURE VIA SKIN CONTACT 11430 0.6076
7 SKIN WEEPING 1717 0.5714
8 ECZEMA EYELIDS 275 0.5522
9 EYELID SKIN DRYNESS 609 0.5491
See all enriched reactions for DUPILUMAB